$11.38
20.75%
Nasdaq, Mon, Jul 07 2025
ISIN
US30234E1047
Symbol
EYEN
Sector
Industry

Eyenovia, Inc. Stock News

Neutral
PRNewsWire
19 days ago
NEW YORK , June 18, 2025 /PRNewswire/ -- Chardan, a leading global investment banking and advisory firm, today announced an expansion into the digital asset sector, advising on and structuring a series of transactions that bridge traditional capital markets with the rapidly evolving world of blockchain and cryptocurrency. As part of its strategic push into crypto finance, Chardan has recently s...
Neutral
GlobeNewsWire
20 days ago
EYEN to bring on major Hyperliquid Thought Leader to support HYPE Treasury Strategy EYEN to bring on major Hyperliquid Thought Leader to support HYPE Treasury Strategy
Positive
Market Watch
20 days ago
Eyenovia shares more than doubled as the company entered a $50 million investment agreement and said it plans to launch a hyperliquid cryptocurrency treasury reserve strategy.
Neutral
GlobeNewsWire
20 days ago
Announces private placement EYEN to become first U.S.-based publicly listed company to hold HYPE in its treasury Hyunsu Jung appointed Chief Investment Officer and Board Member LAGUNA HILLS, Calif., June 17, 2025 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN) (“Eyenovia” or the “Company”) today announced that it has entered into a securities purchase agreement (the “SPA”) for a $50 million p...
Neutral
GlobeNewsWire
about 2 months ago
Eyenovia and Betaliq continue to negotiate a binding merger agreement consistent with the previously announced signed Letter of Intent
Neutral
GlobeNewsWire
3 months ago
On track for regulatory submission seeking marketing approval of the Optejet UFD in Q4 2025 On track for regulatory submission seeking marketing approval of the Optejet UFD in Q4 2025
Neutral
GlobeNewsWire
4 months ago
Combination, if successful, would create a new publicly-listed eye care company combining Betaliq's EyeSol ® water-free drug delivery technology for glaucoma with Eyenovia's Optejet ® device platform
Neutral
GlobeNewsWire
4 months ago
NEW YORK, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN) (“Eyenovia” or the “Company"), an ophthalmic technology company focused on completing development of its proprietary Optejet® device, today announced that it has been informed by staff of The Nasdaq Stock Market LLC that the Company has regained compliance with all Nasdaq Capital Market continued listing requirements, inc...

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today